老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

费森尤斯医疗

22.26
+0.23001.04%
盘后：22.260.00000.00%16:37 EDT
成交量：36.11万
成交额：801.84万
市值：130.67亿
市盈率：11.29
高：22.31
开：22.30
低：21.99
收：22.03
52周最高：30.46
52周最低：20.95
股本：5.87亿
流通股本：4.18亿
量比：0.53
换手率：0.09%
股息：0.84
股息率：3.79%
每股收益(TTM):1.97
每股收益(LYR):1.97
净资产收益率：7.93%
总资产收益率：3.62%
市净率：0.85
市盈率(LYR):11.29

数据加载中...

总览公司新闻资讯公告
2023/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/06/29

员工持股计划

11-K - Annual report of employee stock purchase, savings and similar plans
2022/02/22

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/06/28

员工持股计划

11-K - Annual report of employee stock purchase, savings and similar plans
2021/02/23

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/10/29

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/10/29

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/06/26

员工持股计划

11-K - Annual report of employee stock purchase, savings and similar plans
2020/02/20

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/10/31

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/06/27

员工持股计划

11-K - Annual report of employee stock purchase, savings and similar plans
2019/06/07

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2019/02/20

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2018/08/15

SEC问询函

CORRESP [Cover] - Correspondence
2018/07/10

SEC问询函

CORRESP [Cover] - Correspondence
2018/06/29

员工持股计划

11-K - Annual report of employee stock purchase, savings and similar plans
2016/12/01

非美公司披露报告

公告-费森尤斯医疗将专注于账本IFRS报告和停止美国公认会计准则的财务报表
2016/11/17

非美公司披露报告

材料外国发行人的信息披露
2016/10/27

非美公司披露报告

材料外国发行人的信息披露
2016/10/27

非美公司披露报告

& Co .公司
更多